Pharvaris N.V.(PHVS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
PHVS Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Pharvaris N.V. (PHVS), a Healthcare sector company. PHVS is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of PHVS by reported 13-F value include GENERAL ATLANTIC, L.P., FMR, Foresite Capital Management IV,, based on the most recent SEC filings. PHVS trades on the Nasdaq exchange and files with the SEC under CIK 1830487. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PHVS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pharvaris N.V. directly from SEC EDGAR.
Get alerted when PHVS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Pharvaris N.V. including:
Top Institutional Holders of PHVS
GENERAL ATLANTIC, L.P.
$226.9M8,031,252 shFMR LLC
$177.5M6,284,472 shForesite Capital Management IV, LLC
$135.0M4,778,581 shvenBio Partners LLC
$131.1M4,639,304 shVIKING GLOBAL INVESTORS LP
$103.2M3,653,310 shEQT Fund Management S.a r.l.
$96.7M3,424,609 shDEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$88.3M3,126,042 shBain Capital Life Sciences Investors, LLC
$75.6M2,675,509 shWELLINGTON MANAGEMENT GROUP LLP
$59.9M2,118,900 shCommodore Capital LP
$54.2M1,918,970 sh
| Fund | Value | Shares |
|---|---|---|
| GENERAL ATLANTIC, L.P. | $226.9M | 8,031,252 |
| FMR LLC | $177.5M | 6,284,472 |
| Foresite Capital Management IV, LLC | $135.0M | 4,778,581 |
| venBio Partners LLC | $131.1M | 4,639,304 |
| VIKING GLOBAL INVESTORS LP | $103.2M | 3,653,310 |
| EQT Fund Management S.a r.l. | $96.7M | 3,424,609 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | $88.3M | 3,126,042 |
| Bain Capital Life Sciences Investors, LLC | $75.6M | 2,675,509 |
| WELLINGTON MANAGEMENT GROUP LLP | $59.9M | 2,118,900 |
| Commodore Capital LP | $54.2M | 1,918,970 |
More Healthcare Companies
View all Healthcare →Put PHVS on your watchlist
Track score changes the day Pharvaris N.V. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is PHVS a good stock to buy?
13F Pro's AI-powered analysis of Pharvaris N.V. (PHVS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PHVS are available on the PHVS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own PHVS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PHVS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Pharvaris N.V.'s investment landscape.